Search research articles
Contact Us
Filters
Showing results (171-180 of 202) with videos related to
Page
of 21
Sort By:
Clinical Genitourinary Cancer
|
April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis
Franziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
Cell Reports
|
July 21, 2017
XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1β Activation and Cell Death as a Consequence of TLR-MyD88-Induced cIAP1-TRAF2 Degradation
Kate E Lawlor, Rebecca Feltham, Monica Yabal, et al.
Leukemia
|
April 9, 2016
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance
S Spinner, G Crispatzu, J-H Yi, et al.
EMBO Molecular Medicine
|
June 19, 2016
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma
Katharina Engel, Martina Rudelius, Jolanta Slawska, et al.
International Journal of Antimicrobial Agents
|
March 13, 1999
Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial
A M Been-Tiktak, C A Boucher, F Brun-Vezinet, et al.
ESMO Open
|
March 27, 2026
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study
F Moik, F Huemer, B Doleschal, et al.
Annals of Hematology
|
December 23, 2022
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
Steffen Koschmieder, Susanne Isfort, Dominik Wolf, et al.
Journal for Immunotherapy of Cancer
|
December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study
Dominik A Barth, Florian Moik, Sarah Steinlechner, et al.
American Journal of Hematology
|
April 13, 2020
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes
Juliana Schwaab, Nicole Naumann, Johannes Luebke, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 17, 2025
Early Detection of Cell Death Using Transmembrane Water Exchange Magnetic Resonance Imaging
Athanasia Kaika, Luca Nagel, Ulrike Höckendorf, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 202) with videos related to
Sort By:
Page
of 21
Clinical Genitourinary Cancer
|
April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis
Franziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
Cell Reports
|
July 21, 2017
XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1β Activation and Cell Death as a Consequence of TLR-MyD88-Induced cIAP1-TRAF2 Degradation
Kate E Lawlor, Rebecca Feltham, Monica Yabal, et al.
Leukemia
|
April 9, 2016
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance
S Spinner, G Crispatzu, J-H Yi, et al.
EMBO Molecular Medicine
|
June 19, 2016
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma
Katharina Engel, Martina Rudelius, Jolanta Slawska, et al.
International Journal of Antimicrobial Agents
|
March 13, 1999
Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial
A M Been-Tiktak, C A Boucher, F Brun-Vezinet, et al.
ESMO Open
|
March 27, 2026
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study
F Moik, F Huemer, B Doleschal, et al.
Annals of Hematology
|
December 23, 2022
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
Steffen Koschmieder, Susanne Isfort, Dominik Wolf, et al.
Journal for Immunotherapy of Cancer
|
December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study
Dominik A Barth, Florian Moik, Sarah Steinlechner, et al.
American Journal of Hematology
|
April 13, 2020
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes
Juliana Schwaab, Nicole Naumann, Johannes Luebke, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 17, 2025
Early Detection of Cell Death Using Transmembrane Water Exchange Magnetic Resonance Imaging
Athanasia Kaika, Luca Nagel, Ulrike Höckendorf, et al.
Page
of 21